BioNTech to buy AI-drug discovery company

Thursday 12 January 2023


BioNTech SE, the Germany-based vaccine and immunotherapy company, is to take full control of InstaDeep Ltd having made an equity investment in the company in January 2022. InstaDeep is a UK-based technology company that specialises in artificial intelligence and machine learning. BioNTech has a messenger RNA (mRNA) platform and was responsible, with Pfizer, for commercialising the first Covid-19 vaccine. InstaDeep has its headquarters in London, with offices in Paris, France and four other cities in the Middle East and Africa.